Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optimized vs Standard Ibuprofen Dosing for PDA
NCT00961753Phase 4Terminated
- Sponsor
- OSF HealthCare
- Start
- Aug 2009
- Primary completion
- Oct 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ibuprofen in patent ductus arteriosus (PDA), sponsored by OSF HealthCare. Started Aug 2009; status: terminated.
02
Drugs
ibuprofen
03
Conditions
patent ductus arteriosus (PDA)
Beyond the preview
Go deeper on NCT00961753.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00961753.